Cited 0 times in
Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, H | - |
dc.contributor.author | Kim, EH | - |
dc.contributor.author | Eom, YW | - |
dc.contributor.author | Kim, WH | - |
dc.contributor.author | Kwon, TK | - |
dc.contributor.author | Lee, SJ | - |
dc.contributor.author | Choi, KS | - |
dc.date.accessioned | 2011-04-20T05:20:54Z | - |
dc.date.available | 2011-04-20T05:20:54Z | - |
dc.date.issued | 2006 | - |
dc.identifier.issn | 0008-5472 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/2394 | - |
dc.description.abstract | Sulforaphane is a chemopreventive agent present in various cruciferous vegetables, including broccoli. Here, we show that treatment with tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) in combination with subtoxic doses of sulforaphane significantly induces rapid apoptosis in TRAIL-resistant hepatoma cells. Neither TNF-alpha- nor Fas-mediated apoptosis was sensitized in hepatoma cells by cotreatment with sulforaphane, suggesting that sulforaphane can selectively sensitize cells to TRAIL-induced apoptosis but not to apoptosis mediated by other death receptors. We found that sulforaphane treatment significantly up-regulated mRNA and protein levels of DR5, a death receptor of TRAIL. This was accompanied by an increase in the generation of reactive oxygen species (ROS). Pretreatment with N-acetyl-l-cysteine and overexpression of catalase inhibited sulforaphane-induced up-regulation of DR5 and almost completely blocked the cotreatment-induced apoptosis. Furthermore, the sulforaphane-mediated sensitization to TRAIL was efficiently reduced by administration of a blocking antibody or small interfering RNAs for DR5. These results collectively indicate that sulforaphane-induced generation of ROS and the subsequent up-regulation of DR5 are critical for triggering and amplifying TRAIL-induced apoptotic signaling. We also found that sulforaphane can sensitize both Bcl-xL- and Bcl-2-overexpressing hepatoma cells to TRAIL-induced apoptosis, indicating that treatment with a combination of TRAIL and sulforaphane may be a safe strategy for treating resistant hepatomas. | - |
dc.language.iso | en | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Antineoplastic Combined Chemotherapy Protocols | - |
dc.subject.MESH | Apoptosis | - |
dc.subject.MESH | Apoptosis Regulatory Proteins | - |
dc.subject.MESH | Carcinoma, Hepatocellular | - |
dc.subject.MESH | Cell Line, Tumor | - |
dc.subject.MESH | Drug Screening Assays, Antitumor | - |
dc.subject.MESH | Drug Synergism | - |
dc.subject.MESH | Hepatocytes | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Inhibitor of Apoptosis Proteins | - |
dc.subject.MESH | Liver Neoplasms | - |
dc.subject.MESH | Membrane Glycoproteins | - |
dc.subject.MESH | Promoter Regions, Genetic | - |
dc.subject.MESH | Proto-Oncogene Proteins c-bcl-2 | - |
dc.subject.MESH | Rats | - |
dc.subject.MESH | Reactive Oxygen Species | - |
dc.subject.MESH | Receptors, TNF-Related Apoptosis-Inducing Ligand | - |
dc.subject.MESH | Receptors, Tumor Necrosis Factor | - |
dc.subject.MESH | TNF-Related Apoptosis-Inducing Ligand | - |
dc.subject.MESH | Thiocyanates | - |
dc.subject.MESH | Transcriptional Activation | - |
dc.subject.MESH | Tumor Necrosis Factor-alpha | - |
dc.subject.MESH | Up-Regulation | - |
dc.subject.MESH | bcl-X Protein | - |
dc.title | Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. | - |
dc.type | Article | - |
dc.identifier.pmid | 16452234 | - |
dc.identifier.url | http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=16452234 | - |
dc.contributor.affiliatedAuthor | 김, 욱환 | - |
dc.contributor.affiliatedAuthor | 최, 경숙 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1158/0008-5472.CAN-05-1568 | - |
dc.citation.title | Cancer research | - |
dc.citation.volume | 66 | - |
dc.citation.number | 3 | - |
dc.citation.date | 2006 | - |
dc.citation.startPage | 1740 | - |
dc.citation.endPage | 1750 | - |
dc.identifier.bibliographicCitation | Cancer research, 66(3). : 1740-1750, 2006 | - |
dc.identifier.eissn | 1538-7445 | - |
dc.relation.journalid | J000085472 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.